Teva Pharmaceutical Industries (NYSE: TEVA) had a day on the stock market to remember on Wednesday. The drugmaker 's share price enjoyed a nearly 21% rise on the day, thanks mostly to a very ...

Duquesne Family Office's billionaire boss has gone full contrarian by selling Wall Street's two artificial intelligence (AI) ...

What Happened: A Form 4 filing with the U.S. Securities and Exchange Commission on Monday outlined that Weiss executed a sale ...

Israel-based Phoenix Financial acquired more than 3.5 million additional shares of Teva Pharmaceuticals for an estimated $62.1 million in the third quarter. Post-transaction, the fund reported holding ...

Teva Pharmaceutical Industries Ltd ADR has reached a significant milestone as its stock hit a 52-week high, trading at $25.96. This achievement marks a notable recovery and growth trajectory for the ...

Teva CEO Richard Francis said, "Following the conclusion of the IRA pricing negotiations, we are reiterating our strong ...

Teva shares jumped 12% after Q3 earnings beat estimates, driven by strong branded drug sales led by Austedo and solid ...

Teva Pharmaceutical Industries Ltd ADR stock has reached a new 52-week high, touching 23.07 USD. This milestone reflects a significant upward trend in the company’s stock performance over the past ...

Revenues grew by 3.4 percent to $4.48 billion from $4.33 billion year-on-year, on the back of strong growth across its brands ...

See how Teva Pharmaceutical Industries Limited's growth strategy and focus on specialty medicines are driving a turnaround.

Teva Pharmaceutical (TEVA) stock surges as the company posts better than expected Q3 2025 results and raises the midpoint of ...